Archive: 2005 Early-Stage Life Sciences Technology Conference

April 28, 2005, 12 P.M. - 6 P.M.
The Conference Center at Harvard Medical
77 Avenue Louis Pasteur
Boston, Massachusetts


Keynote panel discussion: A group of senior business development executives from large pharmaceutical companies will discuss their corporate technology needs, their reasons for locating in Massachusetts and their interactions with research institutions.

Formal company presentations:
There will be formal presentations by a select group of early-stage spin-off companies and faculty seeking their first round of professional investment.

Reception and poster session: A networking reception will include poster presentations by all of the presenting companies and by additional institutions and incubating companies.


Noon Lunch

1:00 Panel discussion with leading executives from “Big Pharma” Why have these companies located in Massachusetts? What technologies are they most interested in? What types of partnership deals do they typically make with early-stage companies?


Fran Heller
Head of Strategic Alliances
Novartis Pharmaceuticals

Dr. Robert Gould
Vice President, Licensing and External Research
Merck Research Labs

Dr. Maggie Flanagan
Global Alliance Director for Global Sciences and Information
AstraZeneca Pharmaceuticals

Mike Clark
Strategic Alliances Director
Pfizer Research Technology Center

2:00 Company presentations (12 minutes per company)

4:30 Networking reception and poster session

Sponsorship Information:

$5,000 Sponsorships Available

Sponsorship benefits:

  • Two complementary conference registrations
  • Recognition in pre-event advertising
  • Designation as sponsor in event signage
  • Opportunity to display sponsor literature on literature table
  • Name and/or logo on printed conference materials and Web site
  • One-page service description and contact information in conference book
  • Acknowledgment and thanks at beginning of meeting
  • Early notification of sponsorship¬†opportunities for future events